Physician profile
Ali Hunter
NPI 1306287552
$259.58
in general payments reported to CMS, 2019-2025
8 companies · $62.98 in 2025
The $62.98 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.53 · 2023: $28.57 · 2024: $82.50 · 2025: $62.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $56.81 | 2022 | |
| Lilly USA, LLC | $50.11 | 2024-2025 | Mounjaro, Zepbound |
| Smith+Nephew, INC. | $49.75 | 2023-2024 | Collagenase Santyl, Stravix Pl, Grafix |
| Integra Lifesciences Corporation | $28.72 | 2022 | |
| Becton, Dickinson and Company | $27.62 | 2025 | Arista |
| Xeris Pharmaceuticals, INC. | $21.18 | 2024 | Recorlev |
| Solventum Corporation | $16.02 | 2024 | Abthera, Prevena, Activ.A.C. |
| Rti Surgical, INC | $9.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.